Skip to main content
. 2021 May 31;25(2):276–282. doi: 10.14701/ahbps.2021.25.2.276

Table 3.

iagnosis and treatment

Immunohistochemistry Treatment
Mesenchymal cell (VIMENTIN) (+) Watching and waiting
Marker for stromal cell CD117(−) CD34(−) Radical resection: recurrence 19-77%
Neural cell S-100(−) Non-steroidal anti-inflammatory drugs (NSAIDs)
Beta-catenin (+) Hormonaltherapy non-steroidal benzothiophene (tamoxifen or raloxifen) Interferon Chemotherapy(vinbrastine, methotrexate, doxorubicin and dacarbazine) Imatinib